US Stock MarketDetailed Quotes

OABI OmniAb

Watchlist
  • 4.590
  • -0.190-3.97%
Close Apr 18 16:00 ET
537.61MMarket Cap-9000P/E (TTM)

About OmniAb Company

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Company Profile

SymbolOABI
Company NameOmniAb
Listing DateSep 30, 2021
Founded2015
CEOMr. Matthew W. Foehr
MarketNASDAQ
Employees106
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5980 Horton Street,Suite 600
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-250-7800
Websitehttp://www.omniab.com

Company Executives

  • Name
  • Position
  • Salary
  • Matthew W. Foehr
  • President, Chief Executive Officer and Director
  • 6.66M
  • Kurt A. Gustafson
  • Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
  • 4.97M
  • Charles S. Berkman
  • Chief Legal Officer and Secretary
  • 4.08M
  • John L. Higgins
  • Chairman of the Board
  • 14.58K
  • Steven Love
  • Independent Director
  • --
  • Sarah Boyce
  • Independent Director
  • 10.83K
  • Joshua Tamaroff
  • Independent Director
  • 355.67K
  • Dr. Jennifer R. Cochran, PhD
  • Independent Director
  • 11.67K
  • Dr. Carolyn R. Bertozzi, PhD
  • Independent Director
  • 354.01K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg